Anavex Life Sciences Corp (AVXL)

[VuBru]

My guess is that if the Rett indication is approved by the FDA and the drug marketed, the drug will start being used off label for AD. A good parallel is Neurontin, which was indicated for seizures but generated much of its revenue from wide off-label use for chronic pain. Off-label use will bring in extra revenue even before any AD indication is approved by the FDA. Getting the drug approved for Rett is very important.